Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study

Background: The majority of therapies have generally targeted fasting glucose control, and current mealtime insulin therapies have longer time action profiles than that of endogenously secreted insulin. The primary purpose of this study was to assess both glucose time-in-range (TIR: 70–180 mg/dL) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Akturk, Halis Kaan, Snell-Bergeon, Janet K., Rewers, Amanda, Klaff, Leslie J., Bode, Bruce W., Peters, Anne L., Bailey, Timothy S., Garg, Satish K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161328/
https://www.ncbi.nlm.nih.gov/pubmed/30207748
http://dx.doi.org/10.1089/dia.2018.0200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161328/
https://www.ncbi.nlm.nih.gov/pubmed/30207748
http://dx.doi.org/10.1089/dia.2018.0200

Ejemplares similares